netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Results

Looking for Azacitidine found 5 matches

Open monograph to display formulary status BNF Category
  Azacitidine Malignant disease and immunosuppression - Oestrogens - 08.03.01
  Cytotoxic Drug Azacitidine  (Vidaza) Malignant disease and immunosuppression - Antimetabolites - 08.01.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA218: Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia (08.01.03)
link in drug section TA 399 Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts (08.03.01)
link in drug section TA399 Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts (08.01.03)


 

netFormulary